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disorders of respiratory tract, where there is copious thick 
secretion or mucus production. It has biological half-life 
of 3–4 h. It is absorbed throughout gastrointestinal tract 
(GIT) showing oral bioavailability of about 70–72%. 
Usual initial dose of ambroxol hydrochloride is 30 mg 
thrice a day. Therefore, to reduce frequency of dosing as 
well as to increase bioavailability and enable better patient 
compliance, formulating sustained release dosage form 
was necessary.[1–4] Several sustained release formulations 
of ambroxol hydrochloride have been reported.[5–7]
Chitosan is a biodegradable N-deacetylated product 
INTRODUCTION
Ambroxol is an active N-desmethyl metabolite of the 
mucolytic bromohexine. It is indicated for acute and chronic 
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ABSTRACT
The objective of this study was to investigate the influence of type of cross-linking method used on the 
properties of ambroxol hydrochloride microspheres such as encapsulation efficiency, particle size, and drug 
release. Microspheres were prepared by solvent evaporation technique using chitosan as a matrix-forming 
agent and cross-linked using formaldehyde and heat treatment. Morphological and physicochemical properties 
of microspheres were then investigated by scanning electron microscopy (SEM), X-ray diffractometry (XRD), 
differential scanning calorimetry (DSC), and Fourier-transform infrared spectroscopy (FTIR) spectroscopy. The 
cross-linking of chitosan takes place at the free amino group because of formation of imine bond as evidenced 
by FTIR. The DSC, XRD, and FTIR analysis showed that chitosan microspheres cross linked by heating were 
superior in properties and performance as compared to the microspheres cross-linked using formaldehyde. SEM 
results revealed that heat-treated microspheres were spherical, discrete having smooth, and porous structure. The 
particle size and encapsulation efficiencies of the prepared chitosan microspheres ranged between 10.83–24.11 
µm and 39.73–80.56%, respectively. The drug release was extended up to 12 h, and the kinetics of the drug 
release was obeying Higuchi kinetic proving diffusion-controlled drug release.
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of the polysaccharide, Chitin. It has been used by a 
number of authors as a matrix-forming material in 
microspheres because of its biodegradable nature, 
nontoxicity, biocompatibility, and mucoadhesivity.[8–11] 
These multiparticulate solid dosage forms have a number 
of advantages such as more uniform distribution of the 
drug in the GIT, more uniform drug absorption, reduced 
local irritation, and elimination of unwanted intestinal 
retention of polymeric material. Different methods such 
as ionotropic gelation,[8,12] spray drying,[13,14] emulsification-
solvent evaporation[15,16] are mentioned in the literature for 
preparation of chitosan microspheres.
In this study, we prepared chitosan microspheres using 
solvent evaporation techniques and evaluated the effect 
of methods of cross-linking such as cross-linking by 
chemical such as formaldehyde[17] and cross-linking by heat 
treatment[18] onto the encapsulation efficiency, particle size, 
and drug release. The cross-linked microspheres from the 
optimized formulations were then characterized by FTIR, 
DSC, XRD, and SEM.
MATERIALS AND METHODS
Materials
Ambroxol hydrochloride was obtained as a gift sample 
from Glenmark Pharmaceutical Ltd., Nasik and chitosan 
from Central Fisheries Research Institute, Kochi, India. 
Acetic acid and formaldehyde (35% w/v) solutions were 
purchased from S.D. Fine Chemicals, Mumbai, India. All 
other chemicals used were of analytical grade.
Methods
Preparation of  chitosan microspheres
Initially, chitosan (100 mg) was dissolved in 2 %v/v acetic 
acid solution. The drug (100 mg) was then added to it, and 
the suspension was extruded through syringe in 200 mL of 
1:1 mixture of heavy and light liquid paraffin containing 1 
%w/v SPAN80. The resulting emulsion was then stirred 
using propeller stirrer (Remi’s Equipment, Mumbai) at 
500 rpm. After 30 min, the developed microspheres were 
cross-linked chemically (formaldehyde—FA) or by the heat 
treatment (H), as explained follows:
(a) To produce the FA-crosslinked chitosan microspheres, 1 
mL of formaldehyde was added to emulsion and stirring 
was continued for 6 h. Cross-linked microspheres thus 
formed were separated by filtration, washed repeatedly 
with hexane, followed by water to remove the paraffin, 
acid, and the excess of the cross-linking agent. 
Microspheres were prepared with varying ratios of 
chitosan: drug like 1:1, 2:1, 3:1, and 4:1 and designated 
as, FA-1, FA-2, FA-3, and FA-4, respectively.
(b) To produce the heat treatment cross-linked chitosan 
microspheres, the temperature of the emulsion was 
raised up to 60°C and stirred at 500 rpm overnight. 
The microspheres were then separated by filtration and 
washed repeatedly with hexane followed by water to 
remove acid and paraffin. The resulting microspheres 
prepared with varying ratios of chitosan: drug like 1:1, 
2:1, 3:1, and 4:1 were designated as H-1, H-2 and H-3, 
and H-4, respectively.
Percentage yield of  microspheres
Percent yield value calculated as per the total raw material 
taken as a theoretical amount and the total weight of 
microspheres taken as practical value
Practical value
Percent yield value =  × 100
Theoretical value 
Drug entrapment efficiency
Weighed quantity of microspheres were crushed and 
suspended in distilled water for 24 h to extract the drug 
from microspheres. The filtrate was then analyzed at 244.4 
nm using UV–Vis spectrophotometer (JASCO V630, 
Japan) for drug content. The encapsulation efficiency was 
calculated using following equation:
Encapsulation efficiency = (Drug entrapped/Theoretical 
drug content) × 100.
Particle size analysis of  microspheres
Average particle diameter and size distribution of 
microspheres were determined by laser diffractometry 
using a Mastersizer Micro V 2.19 (Malvern Instruments, 
Malvern, UK). Approximately, 10 mg of microspheres 
were dispersed in 10 mL distilled water containing 0.1 
%v/v Tween 80 for 1 min using an ultrasonic bath. Then, 
an aliquot of the microspheres suspension was added 
into recirculation unit, which was subsequently circulated 
3500 times/min. Particle size was expressed as equivalent 
volume diameter. The analysis was carried out in triplicate. 
The particle size distribution was also expressed in terms 
of SPAN factor determined as:
d90 – d50 
SPAN = 
d10
where d10, d50, and d90 are the diameter sizes, and the given 
percentage value is the percentage of particles smaller 
than that size. A high SPAN value indicates a wide size 
distribution.[14]
Scanning electron micrography
The microspheres were scanned using scanning electron 
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microscope (Leica-Stereoscan-440). For the SEM, the 
microspheres were mounted directly on to the SEM sample 
slab using double-sided sticking tape and coated with gold 
film thickness of 200 mm under reduced pressure of 
0.001 mmHg. The shape and surface characteristic of the 
microspheres was observed under electron microanalyzer 
and photographs were taken using SM 4504 camera.
X-ray diffractometry
X-ray powder diffractometry was carried out to investigate 
the effect of microencapsulation process on crystallinility 
of drug. Powder XRD pattern was recorded on XRD 
(Philips-PW-1050) with filter Ni, Cu Kα radiation, voltage 
40 kV, and a current of 20 mA. The scanning rate employed 
was 1°C/min over the 5° to 50° diffraction angle (2θ) 
range. The XRD patterns of drug powder, polymer, and 
drug-loaded microspheres were recorded.
Differential scanning calorimetry
The DSC analysis of pure drug, polymer, and drug-loaded 
microspheres was carried using DSC (Mettler TC 11, TA 
Processor). The samples (6 mg each) were placed into 
a pierced aluminum sample container. The studies were 
carried out under a static air atmosphere in the temperature 
range of 50–500°C, at a heating rate of 10°C/min. The 
peak temperatures were determined after calibration with 
standard.
Fourier-transform infrared spectroscopy
Drug–polymer interactions were studied by FTIR 
spectroscopy. The spectra were recorded for pure drug, 
polymer, and drug-loaded microspheres using FTIR 
spectrophotometer (Jasco FTIR-410). Samples were 
prepared by KBr disk method and the scanned over the 
range of 400–4000 cm–1, and the resolution was 2/cm.
In vitro drug release studies
Microspheres equivalent to 75 mg ambroxol hydrochloride 
were filled in a capsule[13] and in vitro drug release was 
studied using USP Apparatus I with 900 mL of dissolution 
medium at 37.5 ± 0.1°C for 12 h at 100 rpm. Then, 0.1 
N HCl (pH 1.2) was used as dissolution medium for the 
first 2 h, followed by pH 6.8 phosphate buffer for further 
10 h. Five milliliters mL of sample was withdrawn after 
every hour and was replaced with an equal volume of fresh 
dissolution medium. Collected samples were analyzed at 
244.4 nm spectrophotometrically. The study was performed 
in triplicate. Dissolution study was also conducted for 
marketed capsule Mucolite® SR (M1).
Release kinetics
Data obtained from in vitro release studies were fitted to 
various kinetics equations to find out the mechanism of 
drug release from microspheres. The kinetics models used 
were zero order, first order, and Higuchi models. The rate 
constants were also calculated for the respective models.
RESULTS AND DISCUSSION
This study was undertaken to evaluate the effect of the 
method of cross-linking onto the performance of chitosan 
microspheres. Chitosan was cross-linked chemically using 
formaldehyde or thermally by heat treatment. Ambroxol 
hydrochloride was chosen as the model drug.
Morphology and drug encapsulation efficiency
Thermally cross-linked (H3) microspheres were found to 
be spherical, discrete, and smooth surfaced with distinct 
pores as compared to the microspheres cross-linked using 
formaldehyde [Figure 1]. Drug encapsulation efficiency 
Table 1: Physical characteristics of the ambroxol 
hydrochloride loaded microspheres
Formulation 
code
Drug: 
polymer 
ratio
% Yield Entrapment 
efficiency
Mean particle 
size (μm)
SPAN
FA1 1:1 85.98 68.45 ± 0.745 10.83 ± 0.035 2.146
FA2 1:2 91.45 76.20 ± 0.234 13.81 ± 0.124 2.854
FA3 1:3 89.26 78.57 ± 1.024 16.95 ± 0.078 1.934
FA4 1:4 79.44 80.56 ± 0.928 17.91 ± 0.382 2.301
H1 1:1 95.34 39.73 ± 0.640 18.02 ± 0.463 2.289
H2 1:2 92.68 40.98 ± 1.245 20.82 ± 1.082 2.147
H3 1:3 88.25 45.23 ± 0.735 22.27 ± 0.846 2.032
H4 1:4 80.56 58.65 ± 0.862 24.11 ± 0.628 1.778
Figure 1: Scanning electron micrograph of optimized H3 microsphere 
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was found to be 39.73–58.65% for thermally cross-linked 
microspheres whereas it was 68.45–80.56% for chemically 
cross-linked ones [Table 1]. The high-drug encapsulation 
for formaldehyde cross-linked microspheres could be 
because of formation of more strong and rigid matrix as 
it involves actual chemical reaction between formaldehyde 
and chitosan.
Effect on particle size
Particle  size  for  thermally  cross-linked  chitosan 
microspheres was found to be 18.00–24.11 µm and for 
chitosan microspheres cross-linked by formaldehyde was 
found to be 10.83–17.91 µm. It was seen that the particle 
size of microspheres increased as the concentration of 
polymer increased, and this may be because of the fact that 
increase in polymer concentration causes increase in the 
viscosity of inner phase, which leads to increased cross-
linking. This increased matrix density of polymer may result 
in the increase in the particle size of the microspheres. As 
cross-linking by formaldehyde was more rigid and strong, 
particle size of such microspheres was small as compared 
to thermally cross-linked microspheres. SPAN factor 
ranged in between 1.77 and 2.289, indicating narrow size 
of distribution.
In vitro drug release
In vitro dissolution study revealed that microspheres 
showed sustained drug release beyond 8 h. It was clear 
from Figure 2 that drug-release rate decreased as the 
chitosan concentration increased. The drug release from 
the developed microspheres was biphasic showing initial 
burst effect (rapid drug release) followed by slow diffusion 
of drug. It was also seen that drug release from these 
biodegradable microspheres was also dependent upon 
the type and rigidity of matrix. It was already stated that 
cross-linking by formaldehyde forms more rigid and strong 
matrix due to covalent imine bond formation between 
aldehyde group of formaldehyde and the amino groups of 
chitosan.[12] Therefore, the drug release through FA cross-
linked microspheres was slow as compared to thermally 
cross-linked microspheres.
In vitro dissolution results showed that the H3 and FA3 
microspheres maintained better-sustained action up to a 
period of 12 h. However, cross-linking by chemical agent 
like formaldehyde is harmful because the traces of this 
toxic chemical in the chitosan microspheres can cause 
irritation to mucosal membranes and also it is difficult to 
ensure that the chitosan microspheres are absolutely free 
from the cross-linking agent. Hence, H3 microspheres 
were considered as optimized formulation and it was used 
further evaluated for compatibility study between drug and 
the polymer and surface characterization.
Kinetic treatment of dissolution data
All the formulations followed Higuchi’s kinetics with R2 
ranging from 0.991 to 0.999 [Table 2]. The mechanism of 
drug release was analyzed by Korsmeyer–Peppas equation 
using n value. The value of n varies between 0.22 and 0.35, 
Table 2: Release kinetic of ambroxol hydrochloride-loaded chitosan microspheres
Formulation code Kinetic models
Zero-order First-order Higuchi model Peppas model
R2 K0 (%mg/h) R2 K0 (h–1) R2 Kh (%mg/h1/2) R2 n
FA1 0.9851 4.981 0.927 0.3525 0.9979 33.136 0.9907 0.2710
FA2 0.9765 4.873 0.8115 0.2745 0.9955 30.042 0.9605 0.3123
FA3 0.9691 4.790 0.7689 0.2685 0.9969 28.676 0.9524 0.3896
FA4 0.9909 4.045 0.9777 0.1186 0.9946 24.110 0.9783 0.3595
H1 0.9859 4.611 0.8238 0.4016 0.9991 34.835 0.9603 0.2248
H2 0.9502 4.483 0.8398 0.2832 0.9915 31.328 0.9122 0.26
H3 0.9563 4.210 0.8902 0.1789 0.9934 28.827 0.926 0.2798
H4 0.9696 3.830 0.9341 0.1335 0.997 25.637 0.9426 0.2901
Figure 2: In vitro dissolution profile of ambroxol hydrochloride-loaded 
chitosan microspheres. ● H1; ○ H2; ▲ H3; Δ H4;  F1; ▼ F2, F3; * F4
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which showed Fickian diffusion. The value of kinetic 
constant show decreased trend from 4.87 to 3.83 with 
increased polymer concentration.
Similarity factor (f2) and difference factor (f1) were calculated 
for optimized microspheres considering marketed capsule 
as the reference standard. It was found that f1 and f2 value 
for H3 were 51.83 and 3.06, respectively. This suggested 
that H3 microspheres showed similarities of dissolution 
profiles with that of marketed capsule [Figure 3]. T90% of 
H3 and marketed capsule was 10.3 and 9.48 h, respectively, 
which suggested that these microspheres showed release 
profiles comparable with that of marketed capsule.
X-ray diffractometry
Characteristic crystalline peaks of ambroxol hydrochloride 
was absent in the XRD of ambroxol hydrochloride-loaded 
chitosan microspheres which suggested that drug might be 
in amorphous nature in microspheres [Figure 4].
Differential scanning calorimetry
Endothermic peak of pure ambroxol hydrochloride 
at 243°C was absent in ambroxol-loaded chitosan 
microsphere, which suggested that drug might have shown 
molecular dispersity in microspheres [Figure 5].
Fourier transform infra-red spectroscopy
Characteristic peak of chitosan polymer were located at 
3430 cm–1 for OH group, 1654 cm–1 for carbonyl stretching 
vibration, and at 1616 cm–1 for amino group. In case of 
drug-loaded chitosan microspheres peak at 1719 cm–1 
might be due imine bond formed in cross-linked chitosan 
[Figure 6]. However, the peaks of drug not obtained exactly 
Figure 3: Comparative in vitro dissolution profile of optimized H3 
microspheres with marketed capsule M1. ● M1; ○ H3
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Figure 5: DSC thermograph of ambroxol hydrochloride (A), chitosan 
(B), chitosan-loaded ambroxol hydrochloride loaded microspheres (C)
Figure 4: X-ray diffractograms of ambroxol hydrochloride (A), chitosan 
(B), chitosan-loaded ambroxol hydrochloride loaded microspheres (C)
Figure 6: FTIR spectra of ambroxol hydrochloride (A), chitosan (B), 
chitosan-loaded ambroxol hydrochloride-loaded microspheres (C)
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in drug-loaded microspheres, which suggested that nature 
of drug might be changed to amorphous.
CONCLUSION
This study was designed to evaluate the effect of the 
method of cross-linking onto the performance of chitosan 
microspheres and from the outcome of the investigation 
it can be concluded that though formaldehyde gives better 
cross-linking effect for chitosan microspheres, however, 
due to its toxic nature and inability to remove its traces from 
the microspheres, one has to think about the alternative 
method for cross-linking and heat treatment is found to 
be better alternative as it could control the drug release to 
the desired extent and resulted in excellent microspheres 
with narrow size distribution.
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